Do cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis?
The cell-specific biomarkers of intrathecal inflammation may improve diagnosis and management of neuroimmunological diseases and provide pharmacodynamic markers for future therapeutic developments in patients with intrathecal inflammation that is not captured by imaging, such as in progressive MS.
Epicardial fat tissue may be a useful parameter in the assessment of patients with metabolic syndrome.